ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $351,549 | -11.2% | 19,574 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $396,020 | -1.1% | 19,470 | +5.8% | 0.00% | -25.0% |
| Q1 2023 | $400,362 | -33.0% | 18,399 | -4.6% | 0.00% | -20.0% |
| Q4 2022 | $597,673 | +52.5% | 19,286 | +25.5% | 0.01% | +25.0% |
| Q3 2022 | $392,000 | +15.6% | 15,369 | -8.1% | 0.00% | +33.3% |
| Q2 2022 | $339,000 | -51.8% | 16,721 | -41.2% | 0.00% | -62.5% |
| Q1 2022 | $704,000 | -36.3% | 28,439 | -10.7% | 0.01% | -33.3% |
| Q4 2021 | $1,106,000 | +21.3% | 31,831 | -5.3% | 0.01% | +33.3% |
| Q3 2021 | $912,000 | -2.5% | 33,623 | -6.7% | 0.01% | +12.5% |
| Q2 2021 | $935,000 | -12.3% | 36,045 | -27.1% | 0.01% | -20.0% |
| Q1 2021 | $1,066,000 | +0.5% | 49,474 | +0.2% | 0.01% | -16.7% |
| Q4 2020 | $1,061,000 | +106.4% | 49,352 | +41.8% | 0.01% | +50.0% |
| Q3 2020 | $514,000 | -38.1% | 34,814 | -6.4% | 0.01% | -27.3% |
| Q2 2020 | $831,000 | -56.0% | 37,210 | -31.0% | 0.01% | -26.7% |
| Q3 2019 | $1,887,000 | -40.9% | 53,927 | -4.7% | 0.02% | -37.5% |
| Q2 2019 | $3,191,000 | -32.4% | 56,563 | -12.5% | 0.02% | -27.3% |
| Q1 2019 | $4,720,000 | +19.7% | 64,616 | +4.5% | 0.03% | +6.5% |
| Q4 2018 | $3,943,000 | -7.1% | 61,819 | +45.3% | 0.03% | +10.7% |
| Q3 2018 | $4,244,000 | +75.2% | 42,535 | +24.8% | 0.03% | +75.0% |
| Q2 2018 | $2,422,000 | -26.2% | 34,094 | +8.2% | 0.02% | -38.5% |
| Q1 2018 | $3,280,000 | +25.0% | 31,515 | +21.0% | 0.03% | +44.4% |
| Q4 2017 | $2,623,000 | +274.7% | 26,038 | +30.0% | 0.02% | +260.0% |
| Q3 2017 | $700,000 | +60.6% | 20,034 | +10.0% | 0.01% | +66.7% |
| Q2 2017 | $436,000 | – | 18,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |